Form 4: Yield10 Bioscience Director Acquires Shares in Lieu of Cash Compensation

Director Robert L. Van Nostrand acquired 11,924 shares of Yield10 Bioscience in lieu of cash compensation for board service during Q1 2024.

Summary

• On March 28, 2024, Robert L. Van Nostrand, a director of Yield10 Bioscience, acquired 11,924 shares of common stock.
• The shares were issued in lieu of $4,531 in cash compensation for services rendered as a member of the Board of Directors and/or a committee thereof during the first quarter of 2024.
• Following the transaction, Van Nostrand beneficially owns 48,635 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director taking shares in lieu of cash compensation can be seen as a sign of confidence, but it's a relatively small transaction.

Positives

• The director's decision to take shares in lieu of cash demonstrates confidence in the company's future prospects.

Industry Context

Director share acquisitions are common and can be seen as a positive signal, indicating confidence in the company's performance and future.

Related Party Transactions

• The share issuance to the director in lieu of cash compensation is a related party transaction.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholders as it signals director confidence.

Key Dates

Keywords

Yield10 Bioscience, Director, Share Acquisition, Form 4, YTEN, Compensation, Robert L. Van Nostrand